Status:
RECRUITING
Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
Lead Sponsor:
National Alliance for Sickle Cell Centers
Collaborating Sponsors:
Beam Therapeutics Inc.
Conditions:
Sickle Cell Trait
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences ...
Eligibility Criteria
Inclusion
- Are willing to voluntarily participate and sign the study consent
- Know/suspect they have SCT and are willing to get tested to confirm/learn about their SCT status
- Adults ages 18 and older
Exclusion
- Unwilling to sign consent
- Known end-stage renal disease or dialysis
- Known SCD (including sickle cell-beta thalassemia)
- People who do not have SCT
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06071377
Start Date
April 1 2023
End Date
February 1 2027
Last Update
November 6 2025
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama
Birmingham, Alabama, United States, 35294
2
Loma Linda University Health Care
Loma Linda, California, United States, 92354
3
Nemours Children's Hospital
Wilmington, Delaware, United States, 19803
4
Indiana University
Indianapolis, Indiana, United States, 46202